Connect with us

Hi, what are you looking for?

Editor's Pick

AstraZeneca further cuts target for supply to EU in first quarter to 30 million vaccines: document

World1 hour ago (Mar 11, 2021 08:05PM ET)

(C) Reuters. FILE PHOTO: Coronavirus disease (COVID-19) vaccination in La Baule, France

By Francesco Guarascio

BRUSSELS (Reuters) – AstraZeneca (NASDAQ:AZN) cut its supply forecast of COVID-19 vaccines to the European Union in the first quarter to about 30 million doses, a third of its contractual obligations and a 25% drop from pledges made last month, a document seen by Reuters shows.

The shortfall will represent a further blow to the EU’s vaccination plans, which have been hampered by repeated delays in vaccine supplies and by a slow rollout in some nations.

The document, shared with EU officials and dated March 10, shows that the company now expects to deliver 30.1 million doses by the end of March, and another 20 million in April.

On Feb. 25, AstraZeneca boss Pascal Soriot told the European Parliament that the company would try to deliver 40 million doses by the end of March..

The document shows that on Feb. 24, the Anglo-Swedish company already estimated a supply of only 34 million doses to the EU for the January to March period, well below its contracted target of 90 million doses.

A spokesman for AstraZeneca declined to comment on Friday.

A person familiar with the situation said that the uplift the company had expected for the first quarter did not materialise because of the difficulties of moving vaccines around global supply chains.

The United States, from where AstraZeneca expected to partly supply the EU market, told the EU that it would not export AstraZeneca shots in the near future, Reuters reported on Thursday, citing EU officials.

The company had said its initial supply cuts were caused by production problems in the EU.

“I see efforts, but not “best efforts”. That’s not good enough yet for AstraZeneca to meet its Q1 obligations,” EU industry commissioner Thierry Breton said on Twitter late on Thursday.

“It’s time for AstraZeneca’s Board to exercise its fiduciary responsibility and now do what it takes to fulfil AZ’s commitments,” Breton added.

The AstraZeneca document also shows that the company expects to deliver about 20 million doses to the EU in April. It includes no forecasts for May and June.

Under the contract, AstraZeneca committed to supplying the 27-nation bloc with 180 million doses in the April to June quarter, for a total of 300 million shots from December.

AstraZeneca further cuts target for supply to EU in first quarter to 30 million vaccines: document

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Uncategorized

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt.

Uncategorized

Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione.

Uncategorized

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum.

Uncategorized

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora.

Disclaimer: Buzzclever.com it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial or health advice. Copyright © 2021 Buzz Clever. All Rights Reserved